BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wagner M, Peterson CG, Ridefelt P, Sangfelt P, Carlson M. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 2008; 14(36): 5584-5589 [PMID: 18810778 DOI: 10.3748/wjg.14.5584]
URL: https://www.wjgnet.com/1007-9327/full/v14/i36/5584.htm
Number Citing Articles
1
Peng Fei, Junliang Chen, Yichao Jiang, Hongjian Bai, Yanyan Wang, Ying Han, Min Xing, Ling Guo. Rotavirus-Induced Diarrhea Changes the Proteins, Amino Acids and Fatty Acids Profiles in Fecal Samples of the InfantsIranian Journal of Pediatrics 2021; 31(1) doi: 10.5812/ijp.100031
2
Ibrahim Masoodi, Rakesh Kochhar, Usha Dutta, Chetana Vaishnavi, K. K. Prasad, Kim Vaiphei, Shabnum Hussain, Kartar Singh. Evaluation of Fecal Myeloperoxidase as a Biomarker of Disease Activity and Severity in Ulcerative ColitisDigestive Diseases and Sciences 2012; 57(5): 1336 doi: 10.1007/s10620-012-2027-5
3
Mohsen Hanifeh, Romy M. Heilmann, Satu Sankari, Minna M. Rajamäki, Laura Mäkitalo, Pernilla Syrjä, Susanne Kilpinen, Jan S. Suchodolski, Jörg M. Steiner, Thomas Spillmann. S100A12 concentrations and myeloperoxidase activity in the intestinal mucosa of healthy dogsBMC Veterinary Research 2015; 11(1) doi: 10.1186/s12917-015-0551-1
4
Ren Mao, Ying-lian Xiao, Xiang Gao, Bai-li Chen, Yao He, Li Yang, Pin-jin Hu, Min-hu Chen. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studiesInflammatory Bowel Diseases 2012; 18(10): 1894 doi: 10.1002/ibd.22861
5
M. Koláček, J. Muchová, M. Dvořáková, Z. Paduchová, I. Žitňanová, I. Čierna, Z. Országhová, D. Székyová, N. Jajcaiová-Zedníčková, L. Kovács, Z. Ďuračková. Effect of natural polyphenols (Pycnogenol) on oxidative stress markers in children suffering from Crohn's disease – a pilot studyFree Radical Research 2013; 47(8): 624 doi: 10.3109/10715762.2013.807508
6
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical settingWorld Journal of Gastroenterology 2018; 24(33): 3681-3694 doi: 10.3748/wjg.v24.i33.3681
7
Mirko Di Ruscio, Filippo Vernia, Antonio Ciccone, Giuseppe Frieri, Giovanni Latella. Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?Inflammatory Bowel Diseases 2018; 24(1): 78 doi: 10.1093/ibd/izx011
8
Aart Mookhoek, Maria L Haasnoot, Albert J Bredenoord, Christopher Ma, Vipul Jairath, Rish K Pai. The Clinical Significance of Eosinophils in Ulcerative Colitis: A Systematic ReviewJournal of Crohn's and Colitis 2022; 16(8): 1321 doi: 10.1093/ecco-jcc/jjac024
9
Shingo HINO, Hiroyuki ITO, Hiroyuki BITO, Hirokazu KAWAGISHI, Tatsuya MORITA. Ameliorating Effects of Short-Chain Inulin-Like Fructans on the Healing Stage of Trinitrobenzene Sulfonic Acid-Induced Colitis in RatsBioscience, Biotechnology, and Biochemistry 2011; 75(11): 2169 doi: 10.1271/bbb.110460
10
Maureen C. Turina, Robert Landewé, Dominique Baeten. Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpAExpert Review of Clinical Immunology 2017; 13(4): 333 doi: 10.1080/1744666X.2017.1244004
11
Natalia Pedersen, Pia Munkholm. Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative ColitisInflammatory Bowel Diseases 2015; 21(8): E15 doi: 10.1097/MIB.0000000000000484
12
Jose-Manuel Benitez, Marie-Alice Meuwis, Catherine Reenaers, Catherine Van Kemseke, Paul Meunier, Edouard Louis. Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoringGut 2013; 62(12): 1806 doi: 10.1136/gutjnl-2012-303957
13
Taina Sipponen. Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and LactoferrinDigestive Diseases 2013; 31(3-4): 336 doi: 10.1159/000354689
14
Devis Benfaremo, Michele Maria Luchetti, Armando Gabrielli. Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet NeedsJournal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/8630871
15
James D. Falvey, Teagan Hoskin, Berrie Meijer, Anna Ashcroft, Russell Walmsley, Andrew S. Day, Richard B. Gearry. Disease Activity Assessment in IBDInflammatory Bowel Diseases 2015; 21(4): 824 doi: 10.1097/MIB.0000000000000341
16
Michael Wagner, Klas Sjöberg, Lina Vigren, Martin Olesen, Cecilia Benoni, Ervin Toth, Marie Carlson. Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrheaScandinavian Journal of Gastroenterology 2016; 51(7): 835 doi: 10.3109/00365521.2016.1141432
17
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve, Francisco Rodríguez-Moranta. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel diseaseGastroenterología y Hepatología (English Edition) 2018; 41(8): 514 doi: 10.1016/j.gastre.2018.05.018
18
Michael Wagner, Mats Stridsberg, Christer G. B. Peterson, Per Sangfelt, Maria Lampinen, Marie Carlson. Increased Fecal Levels of Chromogranin A, Chromogranin B, and Secretoneurin in Collagenous ColitisInflammation 2013; 36(4): 855 doi: 10.1007/s10753-013-9612-4
19
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel DiseaseGastrointestinal Endoscopy Clinics of North America 2016; 26(4): 641 doi: 10.1016/j.giec.2016.06.005
20
Teagan S. Edwards, Andrew S. Day. The role of fecal biomarkers in individuals with inflammatory bowel diseaseExpert Review of Molecular Diagnostics 2024; 24(6): 497 doi: 10.1080/14737159.2024.2375224
21
James Turvill. Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapyFrontline Gastroenterology 2014; 5(3): 167 doi: 10.1136/flgastro-2014-100441
22
Akhilesh Swaminathan, Grace M Borichevsky, Teagan S Edwards, Esther Hirschfeld, Thomas C Mules, Chris M A Frampton, Andrew S Day, Mark B Hampton, Anthony J Kettle, Richard B Gearry. Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2022; 16(12): 1862 doi: 10.1093/ecco-jcc/jjac098
23
V. Kristensen, P. Klepp, M. Cvancarova, A. Roseth, V. Skar, B. Moum. Prediction of Endoscopic Disease Activity in Ulcerative Colitis by Two Different Assays for Fecal CalprotectinJournal of Crohn's and Colitis 2015; 9(2): 164 doi: 10.1093/ecco-jcc/jju015
24
Veljko Maric, Milan Jovanovic, Natasa Zdravkovic, Marina Jovanovic, Nevena Gajovic, Milena Jurisevic, Marina Jovanovic, Ivan Jovanovic. Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe DiseaseSerbian Journal of Experimental and Clinical Research 2020; 21(3): 239 doi: 10.2478/sjecr-2018-0034
25
Philipp Lenz, Dominik Bettenworth, Philipp Krausewitz, Markus Brückner, Steffi Ketelhut, Gert von Bally, Dirk Domagk, Björn Kemper. Digital holographic microscopy quantifies the degree of inflammation in experimental colitisIntegrative Biology 2013; 5(3): 624 doi: 10.1039/c2ib20227a
26
James Turvill, Lisa Rook, Maxine Rawle, Gerry Robins, Simon Smale, Prashant Kant, Anne Phillips. Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's diseaseFrontline Gastroenterology 2017; 8(3): 183 doi: 10.1136/flgastro-2016-100780
27
Belal Chami, Patrick T. San Gabriel, Stephen Kum-Jew, XiaoSuo Wang, Nina Dickerhof, Joanne M. Dennis, Paul K. Witting. The nitroxide 4-methoxy-tempo inhibits the pathogenesis of dextran sodium sulfate-stimulated experimental colitisRedox Biology 2020; 28: 101333 doi: 10.1016/j.redox.2019.101333
28
Karin Leder, John J Openshaw, Pascale Allotey, Ansariadi Ansariadi, S Fiona Barker, Kerrie Burge, Thomas F Clasen, Steven L Chown, Grant A Duffy, Peter A Faber, Genie Fleming, Andrew B Forbes, Matthew French, Chris Greening, Rebekah Henry, Ellen Higginson, David W Johnston, Rachael Lappan, Audrie Lin, Stephen P Luby, David McCarthy, Joanne E O'Toole, Diego Ramirez-Lovering, Daniel D Reidpath, Julie A Simpson, Sheela S Sinharoy, Rohan Sweeney, Ruzka R Taruc, Autiko Tela, Amelia R Turagabeci, Jane Wardani, Tony Wong, Rebekah Brown. Study design, rationale and methods of the Revitalising Informal Settlements and their Environments (RISE) study: a cluster randomised controlled trial to evaluate environmental and human health impacts of a water-sensitive intervention in informal settlements in Indonesia and FijiBMJ Open 2021; 11(1): e042850 doi: 10.1136/bmjopen-2020-042850
29
Xiaorong Su, Zhen-hua Zhu, Lin Zhang, Qian Wang, Ming-ming Xu, Cai Lu, Yue Zhu, Jianguo Zeng, Jin-Ao Duan, Ming Zhao. Anti-inflammatory property and functional substances of Lonicerae Japonicae CaulisJournal of Ethnopharmacology 2021; 267: 113502 doi: 10.1016/j.jep.2020.113502
30
Anders Lasson, Lena Öhman, Per-Ove Stotzer, Stefan Isaksson, Otto Überbacher, Kjell-Arne Ung, Hans Strid. Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled studyUnited European Gastroenterology Journal 2015; 3(1): 72 doi: 10.1177/2050640614560785
31
Gary R Lichtenstein, Dermot P B McGovern. Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current StatusThe American Journal of Gastroenterology Supplements 2016; 3(3): 17 doi: 10.1038/ajgs.2016.17
32
Abdelrahim Alqudah, Esam Qnais, Omar Gammoh, Yousra Bseiso, Mohammed Wedyan, Mohammad Alqudah, Taher Hatahet. Cirsimaritin Alleviates Dextran Sodium Sulfate-Induced Acute Colitis in Experimental Animals: A Therapeutic Approach for Inflammatory Bowel DiseasePreventive Nutrition and Food Science 2024; 29(1): 31 doi: 10.3746/pnf.2024.29.1.31
33
Michael Wagner, Christer G. B. Peterson, Ingrid Stolt, Per Sangfelt, Margret Agnarsdottir, Maria Lampinen, Marie Carlson. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot studyScandinavian Journal of Gastroenterology 2011; 46(7-8): 849 doi: 10.3109/00365521.2011.571707
34
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve, Francisco Rodríguez-Moranta. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinación de calprotectina fecal en la enfermedad inflamatoria intestinalGastroenterología y Hepatología 2018; 41(8): 514 doi: 10.1016/j.gastrohep.2018.05.029
35
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatmentEuropean Journal of Gastroenterology & Hepatology 2020; 32(9): 1091 doi: 10.1097/MEG.0000000000001731
36
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan. Fecal calprotectin: its scope and utility in the management of inflammatory bowel diseaseJournal of Gastroenterology 2016; 51(5): 434 doi: 10.1007/s00535-016-1182-4
37
Xu Zhang, Shelley A. Deeke, Zhibin Ning, Amanda E. Starr, James Butcher, Jennifer Li, Janice Mayne, Kai Cheng, Bo Liao, Leyuan Li, Ruth Singleton, David Mack, Alain Stintzi, Daniel Figeys. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel diseaseNature Communications 2018; 9(1) doi: 10.1038/s41467-018-05357-4
38
Sachin Kadian, Sarath Gopalakrishnan, Vidhya Selvamani, Sadid Khan, Trevor Meyer, Rithu Thomas, Muhammad Masud Rana, Pedro P. Irazoqui, Mohit S. Verma, Rahim Rahimi. Smart Capsule for Targeted Detection of Inflammation Levels Inside the GI TractIEEE Transactions on Biomedical Engineering 2024; 71(5): 1565 doi: 10.1109/TBME.2023.3343337
39
Anne-Claire Frin, Jérôme Filippi, Gilles Boschetti, Bernard Flourie, Jocelyne Drai, Patricia Ferrari, Xavier Hebuterne, Stéphane Nancey. Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitisDigestive and Liver Disease 2017; 49(1): 11 doi: 10.1016/j.dld.2016.09.001
40
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis OrganisationRevista de Gastroenterología de México (English Edition) 2017; 82(1): 46 doi: 10.1016/j.rgmxen.2016.07.003
41
Nour Eissa, Hayam Hussein, Diane M. Tshikudi, Geoffrey N. Hendy, Charles N. Bernstein, Jean-Eric Ghia. Interdependence between Chromogranin-A, Alternatively Activated Macrophages, Tight Junction Proteins and the Epithelial Functions. A Human and In-Vivo/In-Vitro Descriptive StudyInternational Journal of Molecular Sciences 2020; 21(21): 7976 doi: 10.3390/ijms21217976
42
Jason Orlando Dimitri Musci, Jack Stephen Cornish, Jan Däbritz. Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseasesJournal of Gastroenterology 2016; 51(6): 531 doi: 10.1007/s00535-016-1191-3
43
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman. Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis OrganisationRevista de Gastroenterología de México 2017; 82(1): 46 doi: 10.1016/j.rgmx.2016.07.003
44
Ignazio Brusca. Biomarcatori nelle malattie infiammatorie intestinaliLa Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine 2013; 9(3): 123 doi: 10.1007/s13631-013-0012-4
45
Anneline Cremer, Jade Ku, Leila Amininejad, Marie-Rose Bouvry, Fabian Brohet, Claire Liefferinckx, Jacques Devière, André van Gossum, Julie Smet, Patrick Stordeur, Denis Franchimont. Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control StudyJournal of Crohn's and Colitis 2019; 13(11): 1372 doi: 10.1093/ecco-jcc/jjz069
46
Mariann Rutka, Renáta Bor, Anita Bálint, Anna Fábián, Ágnes Milassin, Ferenc Nagy, Zoltán Szepes, Mónika Szűcs, László Tiszlavicz, Klaudia Farkas, Tamás Molnár. Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the ColorectumMediators of Inflammation 2016; 2016: 1 doi: 10.1155/2016/2492081
47
Shiyang Li, Ning Yuan, Wei Guo, Yuan Chai, Yi Song, Yuanhui Zhao, Mingyong Zeng, Haohao Wu. Antioxidant and anti-inflammatory protective effects of yellowtail (Seriola quinqueradiata) milt hydrolysates on human intestinal epithelial cells in vitro and dextran sodium sulphate-induced mouse colitis in vivoFood & Function 2022; 13(18): 9169 doi: 10.1039/D2FO00967F
48
Belal Chami, Nathan J.J. Martin, Joanne M. Dennis, Paul K. Witting. Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel diseaseArchives of Biochemistry and Biophysics 2018; 645: 61 doi: 10.1016/j.abb.2018.03.012
49
Maria E. Moscandrew, Edward V. Loftus. Diagnostic advances in inflammatory bowel disease (imaging and laboratory)Current Gastroenterology Reports 2009; 11(6): 488 doi: 10.1007/s11894-009-0074-7
50
Francisco Rodríguez-Moranta, Triana Lobatón, Lorena Rodríguez-Alonso, Jordi Guardiola. Calprotectina fecal en el diagnóstico de enfermedades inflamatoriasGastroenterología y Hepatología 2013; 36(6): 400 doi: 10.1016/j.gastrohep.2012.10.008
51
Inbar Weinstein-Nakar, Gili Focht, Peter Church, Thomas D. Walters, Guila Abitbol, Sudha Anupindi, Laureline Berteloot, Jessie M. Hulst, Frank Ruemmele, Daniel A. Lemberg, Steven T. Leach, Ruth Cytter, Mary-Louise Greer, Anne M. Griffiths, Dan Turner. Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn’s DiseaseClinical Gastroenterology and Hepatology 2018; 16(7): 1089 doi: 10.1016/j.cgh.2018.01.024
52
Maria Elena Rodríguez-Cabezas, Desirée Camuesco, Belén Arribas, Natividad Garrido-Mesa, Mònica Comalada, Elvira Bailón, Margarita Cueto-Sola, Pilar Utrilla, Eduardo Guerra-Hernández, Carlos Pérez-Roca, Julio Gálvez, Antonio Zarzuelo. The combination of fructooligosaccharides and resistant starch shows prebiotic additive effects in ratsClinical Nutrition 2010; 29(6): 832 doi: 10.1016/j.clnu.2010.05.005
53
Laura Mäkitalo, Hanne Rintamäki, Taina Tervahartiala, Timo Sorsa, Kaija-Leena Kolho. Serum MMPs 7–9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2012; 47(7): 785 doi: 10.3109/00365521.2012.677954
54
Fabrizia D'Angelo, Christian Felley, Jean Louis Frossard. Calprotectin in Daily Practice: Where Do We Stand in 2017?Digestion 2017; 95(4): 293 doi: 10.1159/000476062
55
Graham D. Naismith, Lyn A. Smith, Sarah J.E. Barry, Joanna I. Munro, Susan Laird, Karen Rankin, Allan J. Morris, Jack W. Winter, Daniel R. Gaya. A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's diseaseJournal of Crohn's and Colitis 2014; 8(9): 1022 doi: 10.1016/j.crohns.2014.01.029
56
William C. Reisdorf, Qing Xie, Xin Zeng, Wensheng Xie, Neetu Rajpal, Bao Hoang, Mark E. Burgert, Vinod Kumar, Mark R. Hurle, Deepak K. Rajpal, Sarah O’Donnell, Thomas T. MacDonald, Anna Vossenkämper, Lin Wang, Mike Reilly, Bart J. Votta, Yolanda Sanchez, Pankaj Agarwal, Fulvio D'Acquisto. Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel diseasePLOS ONE 2019; 14(4): e0215033 doi: 10.1371/journal.pone.0215033
57
Fang Chen, Yue Hu, Yi-Hong Fan, Bin Lv. Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative ColitisFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.679264
58
G. D. Naismith, L. A. Smith, S. J. E. Barry, J. I. Munro, S. Laird, K. Rankin, A. J. Morris, J. W. Winter, D. R. Gaya. A prospective single‐centre evaluation of the intra‐individual variability of faecal calprotectin in quiescent Crohn's diseaseAlimentary Pharmacology & Therapeutics 2013; 37(6): 613 doi: 10.1111/apt.12221
59
Ahmed Kouki, Wafa Ferjani, Pham My-Chan Dang, Néziha Ghanem-Boughanmi, Abdelaziz Souli, Mossadok Ben-Attia, Jamel El-Benna. Preventive Anti-inflammatory Effects of Apocynin on Acetic Acid–Induced Colitis in RatsInflammation 2024; 47(1): 438 doi: 10.1007/s10753-023-01920-4
60
Vendel Kristensen, Trine Lauritzen, Lars-Petter Jelsness-Jørgensen, Svein Oskar Frigstad, Christian Corwin, Bjørn Moum. Patient-performed extraction of faecal calprotectinClinical Chemistry and Laboratory Medicine (CCLM) 2016; 54(8) doi: 10.1515/cclm-2015-1037
61
Karin Amcoff, Yang Cao, Yaroslava Zhulina, Maria Lampinen, Jonas Halfvarson, Marie Carlson. Prognostic significance of faecal eosinophil granule proteins in inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2019; 54(10): 1237 doi: 10.1080/00365521.2019.1670251
62
Floor van de Logt, Andrew S Day. S100A12: A noninvasive marker of inflammation in inflammatory bowel diseaseJournal of Digestive Diseases 2013; 14(2): 62 doi: 10.1111/1751-2980.12012
63
Andrea Girman. Textbook of Natural Medicine2013; : 211 doi: 10.1016/B978-1-4377-2333-5.00027-4
64
Paula Ministro, Diana Martins. Fecal biomarkers in inflammatory bowel disease: how, when and why?Expert Review of Gastroenterology & Hepatology 2017; 11(4): 317 doi: 10.1080/17474124.2017.1292128
65
Joseph Katzinger. Textbook of Natural Medicine2020; : 227 doi: 10.1016/B978-0-323-43044-9.00028-5
66
Kenta Kaneda, Fumio Saitoh, Hirom Shibusawa, Hidetaka Maegawa, Abbi R. Saniabadi, Nobuhito Kashiwagi, Akihiro Matsukawa. Correlation of neutrophil and monocyte derived interleukin-1 receptor antagonist and interleukin-8 with colitis severity in the rabbitCytokine 2011; 56(2): 508 doi: 10.1016/j.cyto.2011.07.008
67
Sukhminderjit Kaur, Chetana Vaishnavi, Prashant Kapoor, Ibrahim Masoodi. Retrospective assessment of fecal myeloperoxidase activity inClostridium difficileassociated diarrheaJournal of Gastrointestinal Infections 2013; 3(1): 28 doi: 10.5005/jogi-3-1-28
68
David T Rubin, Stephen B Hanauer, Gary R Lichtenstein, Dermot P B McGovern, Miguel D Regueiro, Scott Snapper, Stephan Targan. Refining Treatment Paradigms in Inflammatory Bowel Disease: Assessing the Options for Individualized TherapyThe American Journal of Gastroenterology Supplements 2016; 3(3): 4 doi: 10.1038/ajgsup.2016.15
69
Sarah Fischer, Markus F. Neurath. Precision Medicine in Inflammatory Bowel DiseasesClinical Pharmacology & Therapeutics 2017; 102(4): 623 doi: 10.1002/cpt.793
70
David B. Sachar. Role of Biomarkers in the Study and Management of Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2014; 20(12): 2511 doi: 10.1097/MIB.0000000000000135
71
Margalida Calafat, Eduard Cabré, Míriam Mañosa, Triana Lobatón, Laura Marín, Eugeni Domènech. High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative ColitisInflammatory Bowel Diseases 2015; 21(5): 1072 doi: 10.1097/MIB.0000000000000349
72
Alain M. Schoepfer, Christoph Beglinger, Alex Straumann, Michael Trummler, Pietro Renzulli, Frank Seibold. Ulcerative colitisInflammatory Bowel Diseases 2009; 15(12): 1851 doi: 10.1002/ibd.20986
73
Benjamin F Arnold, Clair Null, Stephen P Luby, Leanne Unicomb, Christine P Stewart, Kathryn G Dewey, Tahmeed Ahmed, Sania Ashraf, Garret Christensen, Thomas Clasen, Holly N Dentz, Lia C H Fernald, Rashidul Haque, Alan E Hubbard, Patricia Kariger, Elli Leontsini, Audrie Lin, Sammy M Njenga, Amy J Pickering, Pavani K Ram, Fahmida Tofail, Peter J Winch, John M Colford. Cluster-randomised controlled trials of individual and combined water, sanitation, hygiene and nutritional interventions in rural Bangladesh and Kenya: the WASH Benefits study design and rationaleBMJ Open 2013; 3(8): e003476 doi: 10.1136/bmjopen-2013-003476
74
Gang Guo, Wen Shi, Feiyu Shi, Wenqing Gong, Fanni Li, Guangju Zhou, Junjun She. Anti‐inflammatory effects of eriocitrin against the dextran sulfate sodium–induced experimental colitis in murine modelJournal of Biochemical and Molecular Toxicology 2019; 33(11) doi: 10.1002/jbt.22400
75
Gerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, Anders Lasson, Ulrich Mittmann, Ken Nally, Laurent Peyrin-Biroulet, Alain Schoepfer, Morten Vatn, Stephan Vavricka, Robert Logan. Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinionJournal of Crohn's and Colitis 2013; 7(8): 670 doi: 10.1016/j.crohns.2013.02.014
76
D. T. Førland, E. Johnson, L. Sætre, T. Lyberg, I. Lygren, G. Hetland. Effect of an Extract Based on the Medicinal Mushroom Agaricus blazei Murill on Expression of Cytokines and Calprotectin in Patients with Ulcerative Colitis and Crohn’s diseaseScandinavian Journal of Immunology 2011; 73(1): 66 doi: 10.1111/j.1365-3083.2010.02477.x
77
Shno Asad, Christine Wegler, David Ahl, Christel A.S. Bergström, Mia Phillipson, Per Artursson, Alexandra Teleki. Proteomics-Informed Identification of Luminal Targets For In Situ Diagnosis of Inflammatory Bowel DiseaseJournal of Pharmaceutical Sciences 2021; 110(1): 239 doi: 10.1016/j.xphs.2020.11.001
78
Taina Sipponen, Clas-Göran AF Björkesten, Martti Färkkilä, Hannu Nuutinen, Erkki Savilahti, Kaija-Leena Kolho. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatmentScandinavian Journal of Gastroenterology 2010; 45(3): 325 doi: 10.3109/00365520903483650
79
Filippo Vernia, Angelo Viscido, Mirko Di Ruscio, Gianpiero Stefanelli, Marco Valvano, Giovanni Latella. Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?Digestion 2021; 102(6): 833 doi: 10.1159/000518419
80
Roberta Caccaro, Renata D’Incá, Giacomo Carlo Sturniolo. Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel diseaseExpert Review of Clinical Immunology 2010; 6(4): 551 doi: 10.1586/eci.10.26
81
Nathan Hargreaves Noguera, Dyana Carla Lima. Natural Plant Products in Inflammatory Bowel Diseases2023; : 173 doi: 10.1016/B978-0-323-99111-7.00003-9
82
Jeremy Meyer, Jacques Schrenzel, Alexandre Balaphas, Vaihere Delaune, Mohamed Abbas, Philippe Morel, Giaccomo Puppa, Laura Rubbia-Brandt, Philippe Bichard, Jean-Louis Frossard, Christian Toso, Nicolas C. Buchs, Frédéric Ris. Mapping of etiologies of computed tomography-proven acute colitis: a prospective cohort studyScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13868-w
83
Yilin Qian, Lei Ma, Mingyong Zeng, Zunying Liu. Amelioration of dextran sulfate sodium-induced colitis by autoinducer-2-deficient Lactiplantibacillus plantarum is mediated by anti-inflammatory effects and alleviation of dysbiosis of the gut microbiotaFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1013586
84
Bincy P. Abraham, Sunanda Kane. Fecal Markers: Calprotectin and LactoferrinGastroenterology Clinics of North America 2012; 41(2): 483 doi: 10.1016/j.gtc.2012.01.007
85
Duk Hwan Kim, Yehyun Park, Bun Kim, Seung Won Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon. Fecal calprotectin as a non‐invasive biomarker for intestinal involvement of Behçet's diseaseJournal of Gastroenterology and Hepatology 2017; 32(3): 595 doi: 10.1111/jgh.13530
86
Maria Cappello, Gaetano Cristian Morreale. The Role of Laboratory Tests in Crohn's DiseaseClinical Medicine Insights: Gastroenterology 2016; 9: CGast.S38203 doi: 10.4137/CGast.S38203
87
Özgür Dandin, Mehmet Levhi Akin, Ahmet Ziya Balta, Ergün Yücel, Dursun Özgür Karakaş, Sezai Demirbaş, Sevim Özdemir, Apdullah Haholu. The Efficacy of Probiotic (Lactobacillus rhamnosus GG) and 5-ASA (Aminosalicylic Acid) in the Treatment of Experimental Radiation Proctitis in RatsIndian Journal of Surgery 2015; 77(S2): 563 doi: 10.1007/s12262-013-0923-3
88
Ennio Lubrano, Michele Maria Luchetti, Devis Benfaremo, Daniele Mauro, Francesco Ciccia, Fabio Massimo Perrotta. Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinicianExpert Review of Clinical Immunology 2021; 17(11): 1199 doi: 10.1080/1744666X.2021.1991315
89
Neil Anderson, Ibnauf Suliman, Tatiana Bandaletova, Austin Obichere, Rupert Lywood, Alexandre Loktionov. Protein biomarkers in exfoliated cells collected from the human rectal mucosa: implications for colorectal disease detection and monitoringInternational Journal of Colorectal Disease 2011; 26(10): 1287 doi: 10.1007/s00384-011-1263-z
90
Kang-Moon Lee. Fecal Biomarkers in Inflammatory Bowel DiseaseIntestinal Research 2013; 11(2): 73 doi: 10.5217/ir.2013.11.2.73
91
Gary R Lichtenstein, Dermot P B McGovern. Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current StatusThe American Journal of Gastroenterology Supplements 2016; 3(3): 17 doi: 10.1038/ajgsup.2016.17
92
Kristen A. Clarkson, Chad K. Porter, Kawsar R. Talaat, Robert W. Frenck, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Robert W. Kaminski, David W. Pascual. Shigella -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei mSphere 2021; 6(4) doi: 10.1128/mSphere.00122-21
93
Thomas A Judd, Andrew S Day, Daniel A Lemberg, Dan Turner, Steven T Leach. Update of fecal markers of inflammation in inflammatory bowel diseaseJournal of Gastroenterology and Hepatology 2011; 26(10): 1493 doi: 10.1111/j.1440-1746.2011.06846.x
94
Anders Lasson, Per-Ove Stotzer, Lena Öhman, Stefan Isaksson, Maria Sapnara, Hans Strid. The intra-individual variability of faecal calprotectin: A prospective study in patients with active ulcerative colitisJournal of Crohn's and Colitis 2014;  doi: 10.1016/j.crohns.2014.06.002
95
Nada Abedin, Teresa Seemann, Sandra Kleinfeld, Jessica Ruehrup, Stefani Röseler, Christian Trautwein, Konrad Streetz, Gernot Sellge. Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel DiseaseJournal of Clinical Medicine 2019; 8(12): 2025 doi: 10.3390/jcm8122025
96
K Takahashi, H Imaeda, T Fujimoto, H Ban, S Bamba, T Tsujikawa, M Sasaki, Y Fujiyama, A Andoh. Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblastsClinical and Experimental Immunology 2013; 173(2): 323 doi: 10.1111/cei.12117
97
Lei Min Yu, Ke Jia Zhao, Shuang Shuang Wang, Xi Wang, Bin Lu. Corticotropin‐releasing factor induces inflammatory cytokines via the NLRP6‐inflammatory cytokine axis in a murine model of irritable bowel syndromeJournal of Digestive Diseases 2019; 20(3): 143 doi: 10.1111/1751-2980.12704
98
Milan Jovanovic, Nevena Gajovic, Natasa Zdravkovic, Marina Jovanovic, Milena Jurisevic, Danilo Vojvodic, Veljko Maric, Aleksandar Arsenijevic, Ivan Jovanovic. Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal CarcinomaMediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/8031328
99
Harland S. Winter, Piotr Krzeski, Melvin B. Heyman, Eduardo Ibarguen‐Secchia, Barbara Iwanczak, Maciej Kaczmarski, Jaroslaw Kierkus, Sanja Kolaček, Bankole Osuntokun, J. Antonio Quiros, Manoj Shah, Bruce Yacyshyn, Preston M. Dunnmon. High‐ and Low‐Dose Oral Delayed‐Release Mesalamine in Children With Mild‐to‐Moderately Active Ulcerative ColitisJournal of Pediatric Gastroenterology and Nutrition 2014; 59(6): 767 doi: 10.1097/MPG.0000000000000530
100
James D. Lewis. The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel DiseaseGastroenterology 2011; 140(6): 1817 doi: 10.1053/j.gastro.2010.11.058
101
Gulfam Ahmad, Belal Chami, Yuyang Liu, Angie L. Schroder, Patrick T. San Gabriel, Antony Gao, Genevieve Fong, XiaoSuo Wang, Paul K. Witting. The Synthetic Myeloperoxidase Inhibitor AZD3241 Ameliorates Dextran Sodium Sulfate Stimulated Experimental ColitisFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.556020
102
Joanne C. Masterson, Eóin N. McNamee, Paul Jedlicka, Sophie Fillon, Joseph Ruybal, Lindsay Hosford, Jesús Rivera-Nieves, James J. Lee, Glenn T. Furuta. CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated RemodelingThe American Journal of Pathology 2011; 179(5): 2302 doi: 10.1016/j.ajpath.2011.07.039
103
Emanuel Burri, Christoph Beglinger, Stefanie von Felten, Frank Serge Lehmann. Fecal Calprotectin and the Clinical Activity Index Are Both Useful to Monitor Medical Treatment in Patients with Ulcerative ColitisDigestive Diseases and Sciences 2015; 60(2): 485 doi: 10.1007/s10620-014-3383-0
104
Cansel Turkay, Benan Kasapoglu. Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An updateClinics 2010; 65(2): 221 doi: 10.1590/S1807-59322010000200015
105
N S Ding, J A K McDonald, A Perdones-Montero, Douglas N Rees, S O Adegbola, R Misra, P Hendy, L Penez, J R Marchesi, E Holmes, M H Sarafian, A L Hart. Metabonomics and the Gut Microbiome Associated With Primary Response to Anti-TNF Therapy in Crohn’s DiseaseJournal of Crohn's and Colitis 2020; 14(8): 1090 doi: 10.1093/ecco-jcc/jjaa039